Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by LAMBOon Oct 12, 2018 8:48am
56 Views
Post# 28786896

Harvesting of 20,000 cannabis plants is underway at LGC.....

Harvesting of 20,000 cannabis plants is underway at LGC.....Harvesting of 20,000 cannabis plants is underway at LGC Capital's Swiss partner, Viridi Unit's Geneva growing facility










MONTREAL, Oct. 12, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) (OTC-PINK: LGGCF) ("LGC") is pleased to announce that Viridi Unit SA ("Viridi") of Switzerland has commenced harvesting of 20,000 plants growing at their Geneva cannabis cultivation facility, consisting of 108,000 square feet of canopy.  
 These plants are expected to yield approximately 3,000 kg of dried cannabis flowers from this current crop for sale within Europe and for use in Viridi's broad range of product offerings in Switzerland and the European Union market.
 Viridi Unit's high-CBD dry cannabis products are sold under the NΞ™ Premium Cannabis brand in over 80 retail locations across Switzerland and the EU and in their cosmetics line under the Viridi Care brand.
 
 
 
 
 
 
 LGC announced a transaction on July 30th, 2018, by which LGC is to acquire a 30% interest in Viridi and a 5% royalty on Viridi's net sales.  Refer to LGC's press release dated July 30th, 2018 for full details on the transaction. This transaction is subject to TSXV approval.

<< Previous
Bullboard Posts
Next >>